Breast cancer patients experience more severe CIPN symptoms with paclitaxel

Chemotherapy-induced peripheral neuropathy (CIPN) – nerve pain, tingling, or numbness in the hands or feet – is a common side effect of certain cancer treatments, including two drugs frequently used to treat cancer – the taxanes paclitaxel and docetaxel.

Related Keywords

Texas ,United States ,Michigan ,American ,Vinayk Gudena ,Daniel Louis Hertz ,Danielle Ellis ,Norah Lynn Henry ,Amyc Vander Woude ,William Johnson Irvin Jr ,Bryanp Schneider ,Thomas Brannagan ,Stephanie Smith ,Michaelj Fisch ,Amy Darke ,Josephm Unger ,Meghnas Trivedi ,Amanda Redden Hathaway ,Community Oncology Research Program ,National Institutes Of Health ,Columbia University Medical Center ,University Of Texas Md Anderson Cancer Center ,Columbia University ,University Of Michigan Rogel Cancer Center ,American Society For Clinical Oncology ,University Cancer Blood Center ,Cancer Hematology Centers Of Western Michigan ,Fred Hutchinson Cancer Center ,Lewis Cancer Research Pavilion At St ,Hope Foundation For Cancer Research ,Cone Health Cancer Center ,Columbia University Herbert Irving Comprehensive Cancer Center ,Bon Secours Cancer Institute At St ,Indiana University ,Data Management Center ,University Of Michigan ,National Cancer Institute ,American Society ,Clinical Oncology ,Cancer Center ,Terminology Criteria ,Adverse Events ,National Institutes ,Oncology Research Program ,Hope Foundation ,Lewis Cancer ,Research Pavilion ,Bon Secours Cancer Institute ,University Cancer ,Blood Center ,Hematology Centers ,Western Michigan ,Michigan Rogel Cancer ,Breast Cancer ,Dancer ,Neuropathy ,Paclitaxel ,Peripheral Neuropathy ,Flood ,Chemotherapy ,Clinical Trial ,Udocetaxel ,Drugs ,Nerve ,Ncology ,Rain ,Research ,